Search

Your search keyword '"Zauderer, M.G."' showing total 7 results
Start Over Author "Zauderer, M.G."
7 results on '"Zauderer, M.G."'

1. COVID-19 in patients with lung cancer

Author

Luo, J., Rizvi, H., Preeshagul, I.R., Egger, J.V., Hoyos, D., Bandlamudi, C., McCarthy, C.G., Falcon, C.J., Schoenfeld, A.J., Arbour, K.C., Chaft, J.E., Daly, R.M., Drilon, A., Eng, J., Iqbal, A., Lai, W.V., Li, B.T., Lito, P., Namakydoust, A., Ng, K., Offin, M., Paik, P.K., Riely, G.J., Rudin, C.M., Yu, H.A., Zauderer, M.G., Donoghue, M.T.A., Łuksza, M., Greenbaum, B.D., Kris, M.G., and Hellmann, M.D.

Published
2020
Full Text
View/download PDF

2. EP07.01-018 Phase III Randomized Trial on Surgery, Chemo and Pleural Radiation (IMPRINT) for Resectable Pleural Mesothelioma (NRG LU-006)

Author

Rimner, A., primary, Hu, C., additional, Simone, C.B., additional, Rusch, V.W., additional, Zauderer, M.G., additional, Gill, R.R., additional, Yorke, E.D., additional, Li, Z., additional, Voong, K.R., additional, Peikert, T., additional, Tsao, M.S., additional, Paulus, R., additional, and Bradley, J.D., additional

Published
2022
Full Text
View/download PDF

3. 192P Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis

Author

Moore, Z.R., primary, Rimner, A., additional, Lobaugh, S., additional, Geyer, A., additional, Gelblum, D.Y., additional, Shepherd, A.F., additional, Shaverdian, N., additional, Wu, A.J., additional, Chaft, J.E., additional, Zauderer, M.G., additional, Rudin, C.M., additional, Vander Els, N., additional, Chawla, M., additional, Jones, D.R., additional, Sopka, D.M., additional, Mak, R., additional, Liao, Z., additional, Gomez, D.R., additional, Zhang, Z., additional, and Paik, P., additional

Published
2022
Full Text
View/download PDF

4. 1639P Integrated safety analysis of tazemetostat (TAZ) 800 mg BID in adult patients (pts) with hematologic and solid tumors

Author

Morschhauser, F., primary, McKay, P., additional, Salles, G., additional, Stacchiotti, S., additional, Schwartz, G.K., additional, Tilly, H., additional, Zauderer, M.G., additional, Fennell, D.A., additional, Jones, R.L., additional, Schöffski, P., additional, Phillips, T., additional, Chaidos, A., additional, Villalobos, V., additional, Demetri, G., additional, Cote, G., additional, Sierra, L., additional, Yang, J., additional, Slatcher, P., additional, Agarwal, S., additional, and Gounder, M., additional

Published
2020
Full Text
View/download PDF

5. Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study

Author

Reckamp, K.L., primary, Akerley, W., additional, Calvo, E., additional, Clarke, J., additional, Edelman, M.J., additional, He, K., additional, Moreno, V., additional, Neal, J.W., additional, Owonikoko, T.K., additional, Patel, J.D., additional, Patel, S.P., additional, Riess, J.W., additional, Sacher, A.G., additional, Turcotte, S., additional, Villaruz, L.C., additional, Zauderer, M.G., additional, Farsaci, B., additional, Skoura, N., additional, Chisamore, M., additional, and Johnson, M.L., additional

Published
2019
Full Text
View/download PDF

6. 1590TiP - Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study

Author

Reckamp, K.L., Akerley, W., Calvo, E., Clarke, J., Edelman, M.J., He, K., Moreno, V., Neal, J.W., Owonikoko, T.K., Patel, J.D., Patel, S.P., Riess, J.W., Sacher, A.G., Turcotte, S., Villaruz, L.C., Zauderer, M.G., Farsaci, B., Skoura, N., Chisamore, M., and Johnson, M.L.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results